Pharmacokinetics, biodistribution and toxicology of novel cell-penetrating peptides

• Published in: Scientific reports Vol. 13; no. 1; pp. 11081 - 13
• Main Authors: Reveret, L., Leclerc, M., Morin, F., Émond, V., Calon, F.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 08-07-2023; Nature Publishing Group; Nature Portfolio
• Subjects: 631/154/436/1729; 631/154/570; 692/4017; Biodistribution; Biological Transport; Blood-brain barrier; Cell-Penetrating Peptides - chemistry; Drug delivery; Drug Delivery Systems; Enantiomers; Endosomes - metabolism; Humanities and Social Sciences; Immunoglobulin G; Injection; multidisciplinary; Peptides; Pharmacokinetics; Science; Science (multidisciplinary); Tissue Distribution; Toxicity; Toxicology
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-023-37280-0

Cell-penetrating peptides (CPPs) have been used in basic and preclinical research in the past 30 years to facilitate drug delivery into target cells. However, translation toward the clinic has not been successful so far. Here, we studied the pharmacokinetic (PK) and biodistribution profiles of Shuttle cell-penetrating peptides (S-CPP) in rodents, combined or not with an immunoglobulin G (IgG) cargo. We compared two enantiomers of S-CPP that contain both a protein transduction domain and an endosomal escape domain, with previously shown capacity for cytoplasmic delivery. The plasma concentration
versus
time curve of both radiolabelled S-CPPs required a two-compartment PK analytical model, which showed a fast distribution phase (t
1/2
α ranging from 1.25 to 3 min) followed by a slower elimination phase (t
1/2
β ranging from 5 to 15 h) after intravenous injection. Cargo IgG combined to S-CPPs displayed longer elimination half-life, of up to 25 h. The fast decrease in plasma concentration of S-CPPs was associated with an accumulation in target organs assessed at 1 and 5 h post-injection, particularly in the liver. In addition, in situ cerebral perfusion (ISCP) of L-S-CPP yielded a brain uptake coefficient of 7.2 ± 1.1 µl g
−1
 s
−1
, consistent with penetration across the blood–brain barrier (BBB), without damaging its integrity in vivo. No sign of peripheral toxicity was detected either by examining hematologic and biochemical blood parameters, or by measuring cytokine levels in plasma. In conclusion, S-CPPs are promising non-toxic transport vectors for improved tissue distribution of drug cargos in vivo.